New Key Statistics Module, Z-Score and F-Score
OTCPK:OSSFF Key Ratios
| Market Cap $ M | 1,867.68 |
| Enterprise Value $ M | 2,308.25 |
| P/E(ttm) | 20.31 |
| PE Ratio without NRI | 20.31 |
| Forward PE Ratio | 18.20 |
| Price/Book | 2.05 |
| Price/Sales | 1.94 |
| Price/Free Cash Flow | 16.52 |
| Price/Owner Earnings | 15.11 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 984.00 |
| EPS (TTM) $ | 0.22 |
| Beneish M-Score | -2.54 |
| 10-y EBITDA Growth Rate % | 7.20 |
| 5-y EBITDA Growth Rate % | 14.70 |
| y-y EBITDA Growth Rate % | 9.40 |
| EV-to-EBIT | 16.45 |
| EV-to-EBITDA | 11.40 |
| PEG | 1.38 |
| Shares Outstanding M | 425.76 |
| Net Margin (%) | 9.54 |
| Operating Margin % | 13.59 |
| Pre-tax Margin (%) | 12.38 |
| Quick Ratio | 0.82 |
| Current Ratio | 1.25 |
| ROA % (ttm) | 5.48 |
| ROE % (ttm) | 10.63 |
| ROIC % (ttm) | 6.63 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.06 |
OSSFF Number of Guru Trades
OSSFF Volume of Guru Trades
Gurus Latest Trades with OTCPK:OSSFF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:OSSFF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Embla Medical hf Insider Transactions
No Available Data
News about OTCPK:OSSFF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers